I understand your sentiments about the length of time involved , however there are a couple of things that could make the wait much shorter.
First of all is the upcomming journal reports from Dr Harris , Dr.Rosenthal , etc.
I have included a quote from Patrick Cox whose expertise I rely on in this area.I believe these and other journal reports will also have a major impact on SP.
Also , remember that as far as tests are concerned , we're not talking about years necessarily as we would a cancer drug.
Viruses (or as NNVClover so eloquently put it "Virii")are a short term "disease".Tests won't take that long.
Please see the following quote.
"Obviously, clinical human tests will be required. Remember, however, the NanoViricides technology works directly on viruses in the bloodstream. Why does this matter? It matters because drugs that work in animal studies but fail in human studies do so for one reason. It is because the human cell is a particularly unique structure with enormously complex mechanisms. A mouse cell is not a human cell, and most drugs work on or in cells. Uniquely, the NanoViricides nanostructure does not.
NanoViricides’ bio/nanotech structures work directly on the virus, no matter where it is found. Though the mechanism of action involves biochemistry, it is in essence a mechanical process. Nanoscale Trojan horses fool viruses by exhibiting ligands that duplicate the external surface of the cells. Viruses respond by doing what they do. They bind to the exposed ligands, thinking they are binding to a cell, enter and release their genomic material in an effort to hijack cells.
In the process, the virus is trapped, dismantled and rendered harmlessly. For that reason, we can extrapolate the success of these studies to human model success with an incredibly high degree of certainty. This is historic, and I’m not even trying to hide my enthusiasm for this company and its technology.
Someday, in fact, I’m convinced historians will look back at this event with the perspective it deserves, just as they remember that milkmaid and Edward Jenner. One scientist told me that he believes the mainstream media haven’t yet caught on to this breakthrough because few science reporters do primary investigative journalism. Instead, they rely on journals to provide leads and data. This, incidentally, is why investors should look forward to Dr. Eva Harris’ inevitable publication of these test results in a peer-reviewed journal. I expect other collaborators to publish as well. When that happens, the cat will be out of the bag."
I hope this helps.
News 
Market Data 
Discover 
AI
